Tag: SARM1 October 26, 2022 New strategy shows potential to block nerve loss in neurodegenerative diseasesResearch into how key molecule triggers axon death may lead to new therapies.News Release October 20, 2020 Startup company founded by Washington University scientists acquired by Eli LillyDrugmaker purchases Disarm Therapeutics to develop treatments for neurodegenerative diseases.Medical Campus & Community July 29, 2019 Extending human lifeTwo new centers focus on chronic diseases of aging.Outlook Magazine January 16, 2019 Gene therapy blocks peripheral nerve damage in miceLays groundwork for developing treatments for peripheral neuropathy, other nerve diseases.News Release Posts navigation
